FDA issues final guidance on pediatric anti-infective development
Regulatory NewsJoanne S. Eglovitch
Clinical TrialsComplianceNorth AmericaPharmaceuticalsPreclinical studyQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchClinical TrialsComplianceNorth AmericaPharmaceuticalsPreclinical studyQuality Assurance and ControlRegulatory Intelligence/Policy